logo
logo

Imagene Bio Appoints Kristin Yarema As Chief Executive Officer

Aug 01, 2025•11 days ago

Position

Chief Executive Officer

Company

ImageneBio

Kristin Yarema
AssamBiopharmaTherapeuticsBiotechnologyHealth Care

Description

ImageneBio granted equity awards to Dr. Kristin Yarema, who was recently appointed as Chief Executive Officer. This event took place on July 28, 2025, and includes inducement stock options and restricted stock units as part of her compensation.

Company Information

Company

ImageneBio

Location

Assam, India

About

ImageneBio is a biopharmaceutical company formed by the merger of Inmagene Biopharmaceuticals and Ikena Oncology. The company focuses on developing innovative treatments for autoimmune and inflammatory diseases. It operates under the ticker symbol 'IMA' on Nasdaq.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months